ARCHIVES

BMS Settles Charges Of Obstructing Generics

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | March 14, 2003

Download PDF Visit The Full Archive

Related Articles

Group Chairman Balk At Board’s Recommendations

February 15, 1980

Bevacizumab And Irinotecan May Increase Survival Of GBM

October 26, 2007

In Brief: Jefferson Cancer Center Received $10 Million donation, Renamed Kimmel Cancer Center

March 29, 1996

In Brief: After Nickles Removes Block, Senate Confirms Oncologist Henney As FDA Commissioner

October 23, 1998

HHS Forms Rural Task Force To Study, Improve Programs.

July 27, 2001

WHI Investigators Reiterate: Breast Cancer, CHD Risks Too Great For Routine HT Use

November 2, 2002